FRONTEO embraces multiple technology platforms, providing a wide variety of options,
to meet the needs of corporate legal departments and law firms globally.
November 14, 2024

UBE and FRONTEO launch co-creation project for drug repositioning using Drug Discovery AI Factory

Accelerate indication identification and early licensing with FRONTEO’s unique technologies that systematically discovers unreported relationships between diseases and molecules from existing literature information.
November 12, 2024

FRONTEO and Daiichi Sankyo signed an agreement for optimization and analysis of toxicity information with Drug Discovery AI Factory

FRONTEO, Inc. (Head Office: Minato-ku, Tokyo; President and CEO: Masahiro Morimoto; hereafter "FRONTEO") is pleased to announce that an agreement has been reached to provide Daiichi Sankyo Co., Ltd. (Head Office: Chuo-ku, Tokyo; President and COO: Hiroyuki Okuzawa; hereafter "Daiichi Sankyo") with analysis services using Drug Discovery AI Factory (hereafter "DDAIF")* to analyze text information from toxicity study databases and reports.
October 28, 2024

Covington & Burling LLP Webinar Report

On 23rd Oct (ET), in collaboration with Covington & Burling LLP, FRONTEO hosted a free webinar on “Compliance and Investigations: What Japanese Companies Can Do During “Peacetime” To Be Best Prepared for U.S. Agency Investigations”.
September 30, 2024

Winston & Strawn LLP Webinar Report

On September 25th (ET), in collaboration with Winston & Strawn LLP, FRONTEO hosted a free webinar on “Update: Revisiting Damages under U.S. Patents for Foreign Conduct".
September 11, 2024

Akerman LLP Webinar Report

On September 11th (ET), in collaboration with Akerman LLP, FRONTEO hosted a free webinar on “Will it Stay or Will it Go? An Update on the Employee Non-Compete Rule in the United States and its Future Prospects, and Beyond”.
August 29, 2024

Knobbe Martens Webinar Report

On August 28th (ET), in collaboration with Knobbe Martens, FRONTEO hosted a free webinar on “Strategic Use of IPRs in Patent Litigation”.
July 4, 2024

Baker & Hostetler LLP Webinar Report

On July 3rd (ET), in collaboration with Baker & Hostetler LLP, FRONTEO hosted a free webinar on “Update from US Antitrust Enforcers”.
June 6, 2024

Davis Polk & Wardwell LLP Webinar Report

On June 6th (ET), in collaboration with Davis Polk & Wardwell LLP, FRONTEO hosted a free webinar on “U.S. Department of Justice Recent Enforcement Trends and Policy Announcements”.
May 30, 2024

Bryan Cave Leighton Paisner LLP Webinar Report

On May 22nd (ET), in collaboration with Bryan Cave Leighton Paisner LLP, FRONTEO hosted a free webinar on “The Long Arm of the Law: Practical Impacts of Recent US Regulatory Changes on Non-US Companies”.
May 13, 2024

FRONTEO, Shionogi, and Suzuken Collaborate to Implement Conversational Dementia Diagnosis Support AI Program in Society

FRONTEO, Inc. (Head Office: Tokyo, Japan; Chief Executive Officer: Masahiro Morimoto; hereafter "FRONTEO"), Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi; hereafter "Shionogi"), and Suzuken Co., Ltd. (Head Office: Nagoya, Japan; President and CEO: Shigeru Asano; hereafter "Suzuken") are pleased to announce that we will collaborate with the aim of implementing the conversational dementia diagnosis support AI program in society.